Company: GVH
Filing Date: 2025-10-01
Form Type: F-3
Source: 0001213900-25-094769
Chunk: 42

Company: Globavend Holdings Ltd
Filing Date: 2025-10-01
Form: F-3
Chunk 42
---
 be delisted from Nasdaq.
Furthermore, on August 22, 2025, Nasdaq filed a proposed rule change with the SEC (File No. SR-NASDAQ-2025-065) pursuant to Rule 19b-4
under the Exchange Act. If approved, a company will not be eligible for the grace period of 180 calendar days if its security has a closing
bid price of $0.10 or less for ten consecutive trading days. The proposed rule change is currently under review by the SEC, with a final
decision expected on or before September 29, 2025. The SEC has not announced any final decision yet.

In addition, Nasdaq Listing
Rule 5810(c)(3)(A)(iii) (the “Low Priced Stock Rule”) provides that if a company’s security has a closing
bid price of $0.10 or less for ten consecutive trading days during any bid price compliance period, Nasdaq must issue a delisting
determination with respect to that security. The closing price of our Ordinary Shares on Nasdaq on September 30, 2025 was $4.59 per share.
A sale of substantial number of Ordinary Shares could depress the trading price of our Ordinary Shares and result in non-compliance of
the Low Priced Stock Rule. If we receive a letter from Nasdaq indicating that we are not compliant with the Low Priced Stock Rule, we
may timely request a hearing before Nasdaq’s hearings panel (the “Hearings Panel”) to appeal the delisting determination,
which would stay the delisting and suspension of our Ordinary Shares pending the decision of the Hearings Panel. No assurances may be
made as to whether our effectuation of a reverse stock would cure any future deficiencies regarding the price of our Ordinary Shares for
purposes of the Low Priced Stock Rule.

If an active trading market does not develop, you may not be able to resell our Ordinary Shares at any reasonable price.

An active trading market
may not develop or, if developed, may not be sustained for the trading of our Ordinary Shares. The lack of an active market may impair
your ability to sell your Ordinary Shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market
may also impair our ability to raise capital by selling Ordinary Shares and may impair our ability to acquire other companies by using
our Ordinary Shares as consideration.

The trading price of our Ordinary Shares could be subject to